25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PYC (Physiomics) Stock Analysis
Buy, Hold or Sell?

Let's analyze Physiomics together

I guess you are interested in Physiomics Plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Physiomics’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Physiomics’s Price Targets

I'm going to help you getting a better view of Physiomics Plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Physiomics Plc

I send you an email if I find something interesting about Physiomics Plc.

1. Quick Overview

1.1. Quick analysis of Physiomics (30 sec.)










1.2. What can you expect buying and holding a share of Physiomics? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p0.09
Expected worth in 1 year
p-0.24
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
p-0.33
Return On Investment
-71.5%

For what price can you sell your share?

Current Price per Share
p0.46
Expected price per share
p0.385 - p0.594
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Physiomics (5 min.)




Live pricePrice per Share (EOD)
p0.46
Intrinsic Value Per Share
p-3.07 - p-1.08
Total Value Per Share
p-2.97 - p-0.99

2.2. Growth of Physiomics (5 min.)




Is Physiomics growing?

Current yearPrevious yearGrowGrow %
How rich?$384.9k$724.5k-$339.5k-88.2%

How much money is Physiomics making?

Current yearPrevious yearGrowGrow %
Making money-$830.3k-$650.3k-$179.9k-21.7%
Net Profit Margin-112.2%-79.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Physiomics (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#744 / 874

Most Revenue
#475 / 874

Most Profit
#227 / 874

Most Efficient
#528 / 874
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Physiomics?

Welcome investor! Physiomics's management wants to use your money to grow the business. In return you get a share of Physiomics.

First you should know what it really means to hold a share of Physiomics. And how you can make/lose money.

Speculation

The Price per Share of Physiomics is p0.46. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Physiomics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Physiomics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p0.09. Based on the TTM, the Book Value Change Per Share is p-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is p-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Physiomics.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps0.00-0.6%0.00-0.6%0.00-0.5%0.00-0.4%0.00-0.3%0.00-0.3%
Usd Book Value Change Per Share0.00-0.2%0.00-0.2%0.00-0.4%0.00-0.3%0.00-0.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.2%0.00-0.2%0.00-0.4%0.00-0.3%0.00-0.1%0.000.0%
Usd Price Per Share0.02-0.02-0.01-0.02-0.05-0.04-
Price to Earnings Ratio-5.97--5.97--6.19--15.83--92.90--63.44-
Price-to-Total Gains Ratio-14.60--14.60--6.67--22.71--33.67--22.37-
Price to Book Ratio12.88-12.88-5.56-9.20-12.06-10.51-
Price-to-Total Gains Ratio-14.60--14.60--6.67--22.71--33.67--22.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.00626796
Number of shares159541
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (159541 shares)-178.66-46.66
Gains per Year (159541 shares)-714.65-186.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-715-7250-187-197
20-1429-14400-373-384
30-2144-21550-560-571
40-2859-28700-747-758
50-3573-35850-933-945
60-4288-43000-1120-1132
70-5003-50150-1306-1319
80-5717-57300-1493-1506
90-6432-64450-1680-1693
100-7147-71600-1866-1880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.022.00.04.3%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%9.014.00.039.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.023.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%9.014.00.039.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Physiomics Plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.082-0.0820%-0.146+78%-0.097+18%-0.021-74%0.005-1806%
Book Value Per Share--0.0930.0930%0.175-47%0.197-53%0.282-67%0.212-56%
Current Ratio--2.8662.8660%4.633-38%5.102-44%6.893-58%6.328-55%
Debt To Asset Ratio--0.3310.3310%0.212+57%0.223+49%0.176+89%0.184+80%
Debt To Equity Ratio--0.4960.4960%0.268+85%0.303+64%0.229+117%0.239+108%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--368950390.400368950390.4000%323020667.200+14%547048028.000-33%1173841285.440-69%855656654.680-57%
Eps---0.201-0.2010%-0.157-22%-0.147-27%-0.107-47%-0.100-50%
Ev To Ebitda Ratio---5.592-5.5920%-5.752+3%-12.877+130%-55.496+892%-38.746+593%
Ev To Sales Ratio--6.7926.7920%5.408+26%7.877-14%16.008-58%13.265-49%
Free Cash Flow Per Share---0.186-0.1860%-0.090-52%-0.131-30%-0.090-52%-0.095-49%
Free Cash Flow To Equity Per Share---0.075-0.0750%-0.090+19%-0.094+25%-0.014-81%0.027-378%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.081----------
Intrinsic Value_10Y_min---3.067----------
Intrinsic Value_1Y_max---0.094----------
Intrinsic Value_1Y_min---0.178----------
Intrinsic Value_3Y_max---0.294----------
Intrinsic Value_3Y_min---0.649----------
Intrinsic Value_5Y_max---0.506----------
Intrinsic Value_5Y_min---1.244----------
Market Cap139476136.320-161%363850790.400363850790.4000%295628767.200+23%517982028.000-30%1120357225.440-68%817527244.680-55%
Net Profit Margin---1.122-1.1220%-0.799-29%-0.742-34%-0.523-53%-0.738-34%
Operating Margin---1.231-1.2310%-0.958-22%-0.874-29%-0.654-47%-0.921-25%
Operating Ratio--2.2852.2850%2.010+14%1.946+17%1.729+32%1.958+17%
Pb Ratio4.937-161%12.87812.8780%5.560+132%9.205+40%12.057+7%10.515+22%
Pe Ratio-2.289+62%-5.971-5.9710%-6.194+4%-15.834+165%-92.902+1456%-63.445+963%
Price Per Share0.460-161%1.2001.2000%0.975+23%1.708-30%3.695-68%2.696-55%
Price To Free Cash Flow Ratio-2.467+62%-6.435-6.4350%-10.889+69%-14.088+119%-123.124+1813%-75.516+1074%
Price To Total Gains Ratio-5.597+62%-14.601-14.6010%-6.672-54%-22.709+56%-33.666+131%-22.372+53%
Quick Ratio--2.4412.4410%4.633-47%4.960-51%6.808-64%5.614-57%
Return On Assets---1.442-1.4420%-0.708-51%-0.792-45%-0.517-64%-0.612-58%
Return On Equity---2.157-2.1570%-0.898-58%-1.105-49%-0.710-67%-0.816-62%
Total Gains Per Share---0.082-0.0820%-0.146+78%-0.097+18%-0.021-74%0.005-1806%
Usd Book Value--384971.290384971.2900%724521.672-47%812588.327-53%1163591.997-67%875567.653-56%
Usd Book Value Change Per Share---0.001-0.0010%-0.002+78%-0.001+18%0.000-74%0.000-1806%
Usd Book Value Per Share--0.0010.0010%0.002-47%0.003-53%0.004-67%0.003-56%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--5027318.0205027318.0200%4401479.611+14%7454076.430-33%15994761.355-69%11659177.577-57%
Usd Eps---0.003-0.0030%-0.002-22%-0.002-27%-0.001-47%-0.001-50%
Usd Free Cash Flow---770472.632-770472.6320%-369943.175-52%-543024.260-30%-371988.710-52%-393622.846-49%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.001-52%-0.002-30%-0.001-52%-0.001-49%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.001+19%-0.001+25%0.000-81%0.000-378%
Usd Market Cap1900501.833-161%4957830.8704957830.8700%4028237.582+23%7058023.114-30%15265987.554-68%11139626.236-55%
Usd Price Per Share0.006-161%0.0160.0160%0.013+23%0.023-30%0.050-68%0.037-55%
Usd Profit---830303.035-830303.0350%-650310.388-22%-608512.633-27%-441481.310-47%-414810.323-50%
Usd Revenue--740232.450740232.4500%813954.560-9%895169.154-17%946254.572-22%759146.701-2%
Usd Total Gains Per Share---0.001-0.0010%-0.002+78%-0.001+18%0.000-74%0.000-1806%
 EOD+3 -5MRQTTM+0 -0YOY+13 -243Y+9 -285Y+3 -3410Y+3 -34

3.3 Fundamental Score

Let's check the fundamental score of Physiomics Plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.289
Price to Book Ratio (EOD)Between0-14.937
Net Profit Margin (MRQ)Greater than0-1.122
Operating Margin (MRQ)Greater than0-1.231
Quick Ratio (MRQ)Greater than12.441
Current Ratio (MRQ)Greater than12.866
Debt to Asset Ratio (MRQ)Less than10.331
Debt to Equity Ratio (MRQ)Less than10.496
Return on Equity (MRQ)Greater than0.15-2.157
Return on Assets (MRQ)Greater than0.05-1.442
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Physiomics Plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.936
Ma 20Greater thanMa 500.468
Ma 50Greater thanMa 1000.448
Ma 100Greater thanMa 2000.445
OpenGreater thanClose0.422
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Physiomics Plc

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

Fundamental data was last updated by Penke on 2025-07-02 07:46:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Physiomics earns for each 1 of revenue.

  • Above 10% is considered healthy but always compareΒ Physiomics to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -112.2%Β means thatΒ -1.12 for each 1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Physiomics Plc:

  • The MRQ is -112.2%. The company is making a huge loss. -2
  • The TTM is -112.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-112.2%TTM-112.2%0.0%
TTM-112.2%YOY-79.9%-32.3%
TTM-112.2%5Y-52.3%-59.9%
5Y-52.3%10Y-73.8%+21.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-112.2%-92.7%-19.5%
TTM-112.2%-140.3%+28.1%
YOY-79.9%-196.4%+116.5%
3Y-74.2%-248.5%+174.3%
5Y-52.3%-343.4%+291.1%
10Y-73.8%-496.2%+422.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Physiomics is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Physiomics to theΒ Biotechnology industry mean.
  • -144.2% Return on Assets means thatΒ Physiomics generatedΒ -1.44 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Physiomics Plc:

  • The MRQ is -144.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -144.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-144.2%TTM-144.2%0.0%
TTM-144.2%YOY-70.8%-73.4%
TTM-144.2%5Y-51.7%-92.5%
5Y-51.7%10Y-61.2%+9.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-144.2%-11.6%-132.6%
TTM-144.2%-11.6%-132.6%
YOY-70.8%-11.4%-59.4%
3Y-79.2%-11.8%-67.4%
5Y-51.7%-12.0%-39.7%
10Y-61.2%-13.7%-47.5%
4.3.1.3. Return on Equity

Shows how efficient Physiomics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Physiomics to theΒ Biotechnology industry mean.
  • -215.7% Return on Equity means Physiomics generated -2.16Β for eachΒ 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Physiomics Plc:

  • The MRQ is -215.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -215.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-215.7%TTM-215.7%0.0%
TTM-215.7%YOY-89.8%-125.9%
TTM-215.7%5Y-71.0%-144.7%
5Y-71.0%10Y-81.6%+10.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-215.7%-13.6%-202.1%
TTM-215.7%-15.0%-200.7%
YOY-89.8%-14.5%-75.3%
3Y-110.5%-16.9%-93.6%
5Y-71.0%-17.5%-53.5%
10Y-81.6%-19.9%-61.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Physiomics Plc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Physiomics is operatingΒ .

  • Measures how much profit Physiomics makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Physiomics to theΒ Biotechnology industry mean.
  • An Operating Margin of -123.1%Β means the company generated -1.23 Β for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Physiomics Plc:

  • The MRQ is -123.1%. The company is operating very inefficient. -2
  • The TTM is -123.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-123.1%TTM-123.1%0.0%
TTM-123.1%YOY-95.8%-27.3%
TTM-123.1%5Y-65.4%-57.7%
5Y-65.4%10Y-92.1%+26.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-123.1%-229.2%+106.1%
TTM-123.1%-249.0%+125.9%
YOY-95.8%-208.5%+112.7%
3Y-87.4%-223.8%+136.4%
5Y-65.4%-346.1%+280.7%
10Y-92.1%-475.5%+383.4%
4.3.2.2. Operating Ratio

Measures how efficient Physiomics is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 2.29 means that the operating costs are 2.29 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Physiomics Plc:

  • The MRQ is 2.285. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.285. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.285TTM2.2850.000
TTM2.285YOY2.010+0.275
TTM2.2855Y1.729+0.556
5Y1.72910Y1.958-0.230
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2852.110+0.175
TTM2.2852.684-0.399
YOY2.0103.096-1.086
3Y1.9463.652-1.706
5Y1.7294.745-3.016
10Y1.9586.614-4.656
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Physiomics Plc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Physiomics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.87Β means the company has 2.87 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Physiomics Plc:

  • The MRQ is 2.866. The company is able to pay all its short-term debts. +1
  • The TTM is 2.866. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.866TTM2.8660.000
TTM2.866YOY4.633-1.767
TTM2.8665Y6.893-4.027
5Y6.89310Y6.328+0.564
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8663.661-0.795
TTM2.8663.846-0.980
YOY4.6334.140+0.493
3Y5.1024.688+0.414
5Y6.8935.746+1.147
10Y6.3286.147+0.181
4.4.3.2. Quick Ratio

Measures if Physiomics is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Physiomics to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.44Β means the company can pay off 2.44 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Physiomics Plc:

  • The MRQ is 2.441. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.441. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.441TTM2.4410.000
TTM2.441YOY4.633-2.191
TTM2.4415Y6.808-4.366
5Y6.80810Y5.614+1.194
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4412.826-0.385
TTM2.4413.182-0.741
YOY4.6333.786+0.847
3Y4.9604.311+0.649
5Y6.8085.703+1.105
10Y5.6146.454-0.840
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Physiomics Plc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of PhysiomicsΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Physiomics to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.33Β means that Physiomics assets areΒ financed with 33.1% credit (debt) and the remaining percentage (100% - 33.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Physiomics Plc:

  • The MRQ is 0.331. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.331. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.331TTM0.3310.000
TTM0.331YOY0.212+0.120
TTM0.3315Y0.176+0.156
5Y0.17610Y0.184-0.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3310.329+0.002
TTM0.3310.349-0.018
YOY0.2120.331-0.119
3Y0.2230.340-0.117
5Y0.1760.349-0.173
10Y0.1840.379-0.195
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Physiomics is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Physiomics to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 49.6% means that company has 0.50 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Physiomics Plc:

  • The MRQ is 0.496. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.496. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.496TTM0.4960.000
TTM0.496YOY0.268+0.227
TTM0.4965Y0.229+0.267
5Y0.22910Y0.239-0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4960.379+0.117
TTM0.4960.437+0.059
YOY0.2680.414-0.146
3Y0.3030.450-0.147
5Y0.2290.464-0.235
10Y0.2390.515-0.276
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every 1 in earnings Physiomics generates.

  • Above 15 is considered overpriced butΒ always compareΒ Physiomics to theΒ Biotechnology industry mean.
  • A PE ratio of -5.97 means the investor is paying -5.97Β for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Physiomics Plc:

  • The EOD is -2.289. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.971. Based on the earnings, the company is expensive. -2
  • The TTM is -5.971. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.289MRQ-5.971+3.682
MRQ-5.971TTM-5.9710.000
TTM-5.971YOY-6.194+0.223
TTM-5.9715Y-92.902+86.931
5Y-92.90210Y-63.445-29.457
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.289-2.304+0.015
MRQ-5.971-2.080-3.891
TTM-5.971-2.564-3.407
YOY-6.194-3.764-2.430
3Y-15.834-3.773-12.061
5Y-92.902-6.193-86.709
10Y-63.445-6.833-56.612
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Physiomics Plc:

  • The EOD is -2.467. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.435. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.435. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.467MRQ-6.435+3.968
MRQ-6.435TTM-6.4350.000
TTM-6.435YOY-10.889+4.454
TTM-6.4355Y-123.124+116.689
5Y-123.12410Y-75.516-47.608
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.467-3.132+0.665
MRQ-6.435-2.705-3.730
TTM-6.435-3.666-2.769
YOY-10.889-4.405-6.484
3Y-14.088-5.059-9.029
5Y-123.124-8.477-114.647
10Y-75.516-9.304-66.212
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Physiomics is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 12.88 means the investor is paying 12.88Β for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Physiomics Plc:

  • The EOD is 4.937. Based on the equity, the company is fair priced.
  • The MRQ is 12.878. Based on the equity, the company is expensive. -2
  • The TTM is 12.878. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4.937MRQ12.878-7.942
MRQ12.878TTM12.8780.000
TTM12.878YOY5.560+7.319
TTM12.8785Y12.057+0.821
5Y12.05710Y10.515+1.543
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.9371.953+2.984
MRQ12.8781.843+11.035
TTM12.8782.112+10.766
YOY5.5602.441+3.119
3Y9.2052.494+6.711
5Y12.0573.661+8.396
10Y10.5154.311+6.204
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in GBP. All numbers in thousands.

Summary
Total Assets423
Total Liabilities140
Total Stockholder Equity283
 As reported
Total Liabilities 140
Total Stockholder Equity+ 283
Total Assets = 423

Assets

Total Assets423
Total Current Assets401
Long-term Assets21
Total Current Assets
Cash And Cash Equivalents 191
Net Receivables 151
Other Current Assets 59
Total Current Assets  (as reported)401
Total Current Assets  (calculated)401
+/-0
Long-term Assets
Property Plant Equipment 17
Intangible Assets 4
Long-term Assets  (as reported)21
Long-term Assets  (calculated)21
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities140
Long-term Liabilities0
Total Stockholder Equity283
Total Current Liabilities
Short-term Debt 37
Accounts payable 35
Other Current Liabilities 84
Total Current Liabilities  (as reported)140
Total Current Liabilities  (calculated)156
+/- 16
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock542
Retained Earnings -7,426
Other Stockholders Equity 7,167
Total Stockholder Equity (as reported)283
Total Stockholder Equity (calculated)283
+/-0
Other
Capital Stock542
Cash and Short Term Investments 191
Common Stock Shares Outstanding 135,368
Current Deferred Revenue34
Liabilities and Stockholders Equity 423
Net Debt -191
Net Invested Capital 283
Net Working Capital 261
Property Plant and Equipment Gross 93



6.2. Balance Sheets Structured

Currency in GBP. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302001-06-30
> Total Assets 
139
79
93
527
146
303
114
275
922
868
840
380
244
379
303
415
818
694
1,446
1,323
1,115
674
423
4236741,1151,3231,4466948184153033792443808408689222751143031465279379139
   > Total Current Assets 
73
12
21
449
82
249
71
238
890
835
813
360
229
370
299
409
813
674
1,431
1,304
1,098
661
401
4016611,0981,3041,4316748134092993702293608138358902387124982449211273
       Cash And Cash Equivalents 
48
3
8
295
26
75
9
95
780
730
691
179
132
267
139
210
572
405
1,048
1,043
688
417
191
1914176881,0431,04840557221013926713217969173078095975262958348
       Net Receivables 
0
0
0
134
0
150
0
119
0
67
86
98
69
66
86
37
50
104
383
261
410
244
151
1512444102613831045037866669988667011901500134000
       Other Current Assets 
25
9
14
154
56
174
61
143
110
37
36
28
83
103
158
162
191
165
308
233
330
212
59
5921233023330816519116215810383283637110143611745615414925
   > Long-term Assets 
66
67
72
78
64
54
43
37
32
33
27
21
15
9
4
6
5
20
15
19
18
13
21
211318191520564915212733323743546478726766
       Property Plant Equipment 
1
4
14
25
15
8
4
2
2
7
6
4
4
2
2
6
5
18
12
16
14
8
17
1781416121856224467224815251441
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000
       Intangible Assets 
65
63
58
53
49
46
39
35
30
26
21
16
12
7
2
-76
0
1
4
3
3
5
4
4533410-762712162126303539464953586365
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000
> Total Liabilities 
9
208
447
114
212
204
468
360
135
112
106
125
108
53
99
87
128
86
132
158
141
143
140
140143141158132861288799531081251061121353604682042121144472089
   > Total Current Liabilities 
9
39
447
114
212
122
318
360
135
112
106
125
108
53
99
87
128
86
132
158
141
143
140
14014314115813286128879953108125106112135360318122212114447399
       Short-term Debt 
0
0
405
0
0
0
8
64
0
0
0
0
0
0
0
0
-68
-1
8
44
14
20
37
372014448-1-680000000064800040500
       Accounts payable 
1
35
28
50
79
65
167
87
90
85
61
57
55
22
39
23
15
26
28
19
27
18
35
3518271928261523392255576185908716765795028351
       Other Current Liabilities 
8
4
14
64
133
57
143
209
45
27
45
68
52
32
61
64
26
44
96
95
100
105
84
8410510095964426646132526845274520914357133641448
   > Long-term Liabilities 
1
169
433
50
79
82
150
151
90
85
61
57
0
0
0
0
0
26
28
19
27
0
0
002719282600000576185901511508279504331691
> Total Stockholder Equity
130
-129
-354
413
-66
99
-354
-85
787
756
735
256
136
326
204
328
690
608
1,315
1,166
975
532
283
2835329751,1661,315608690328204326136256735756787-85-35499-66413-354-129130
   Common Stock
22
67
67
92
93
150
150
250
400
452
599
603
688
993
1,033
1,121
288
288
1,276
1,283
1,283
1,283
542
5421,2831,2831,2831,2762882881,1211,0339936886035994524002501501509392676722
   Retained Earnings -7,426-6,836-6,526-6,273-6,057-5,993-5,889-5,706-5,305-4,926-4,569-4,143-3,643-3,103-2,458-2,091-2,115-1,681-1,488-1,008-626-401-142
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
250
208
211
1,329
1,353
1,630
1,646
1,793
2,883
3,336
3,697
3,704
3,925
4,148
4,328
4,754
5,228
5,228
5,897
5,934
5,936
5,936
7,167
7,1675,9365,9365,9345,8975,2285,2284,7544,3284,1483,9253,7043,6973,3362,8831,7931,6461,6301,3531,329211208250



6.3. Balance Sheets

Currency in GBP. All numbers in thousands.




6.4. Cash Flows

Currency in GBP. All numbers in thousands.




6.5. Income Statements

Currency in GBP. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in GBP. All numbers in thousands.

Gross Profit (+$)
totalRevenue543
Cost of Revenue-1,221
Gross Profit-677-677
 
Operating Income (+$)
Gross Profit-677
Operating Expense-21
Operating Income-671-698
 
Operating Expense (+$)
Research Development0
Selling General Administrative11
Selling And Marketing Expenses0
Operating Expense2111
 
Net Interest Income (+$)
Interest Income2
Interest Expense-0
Other Finance Cost-0
Net Interest Income2
 
Pretax Income (+$)
Operating Income-671
Net Interest Income2
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-669-673
EBIT - interestExpense = -669
-669
-609
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-669-669
Earnings Before Interest and Taxes (EBITDA)-660
 
After tax Income (+$)
Income Before Tax-669
Tax Provision--59
Net Income From Continuing Ops-609-609
Net Income-609
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,241
Total Other Income/Expenses Net2-2
 

Technical Analysis of Physiomics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Physiomics. The general trend of Physiomics is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Physiomics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Physiomics Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Physiomics Plc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.5285 < 0.5655 < 0.594.

The bearish price targets are: 0.4 > 0.396 > 0.385.

Know someone who trades $PYC? Share this with them.πŸ‘‡

Physiomics Plc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Physiomics Plc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Physiomics Plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Physiomics Plc. The current macd is -0.00443174.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Physiomics price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Physiomics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Physiomics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Physiomics Plc Daily Moving Average Convergence/Divergence (MACD) ChartPhysiomics Plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Physiomics Plc. The current adx is 40.05.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Physiomics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Physiomics Plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Physiomics Plc. The current sar is 0.4.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Physiomics Plc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Physiomics Plc. The current rsi is 50.94. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Physiomics Plc Daily Relative Strength Index (RSI) ChartPhysiomics Plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Physiomics Plc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Physiomics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Physiomics Plc Daily Stochastic Oscillator ChartPhysiomics Plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Physiomics Plc. The current cci is -9.44779473.

Physiomics Plc Daily Commodity Channel Index (CCI) ChartPhysiomics Plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Physiomics Plc. The current cmo is 3.52944603.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Physiomics Plc Daily Chande Momentum Oscillator (CMO) ChartPhysiomics Plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Physiomics Plc. The current willr is -47.82608696.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Physiomics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Physiomics Plc Daily Williams %R ChartPhysiomics Plc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Physiomics Plc.

Physiomics Plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Physiomics Plc. The current atr is 0.04652842.

Physiomics Plc Daily Average True Range (ATR) ChartPhysiomics Plc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Physiomics Plc. The current obv is 484,694,403.

Physiomics Plc Daily On-Balance Volume (OBV) ChartPhysiomics Plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Physiomics Plc. The current mfi is 37.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Physiomics Plc Daily Money Flow Index (MFI) ChartPhysiomics Plc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Physiomics Plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Physiomics Plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Physiomics Plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.936
Ma 20Greater thanMa 500.468
Ma 50Greater thanMa 1000.448
Ma 100Greater thanMa 2000.445
OpenGreater thanClose0.422
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Physiomics with someone you think should read this too:
  • Are you bullish or bearish on Physiomics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Physiomics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Physiomics Plc

I send you an email if I find something interesting about Physiomics Plc.


Comments

How you think about this?

Leave a comment

Stay informed about Physiomics Plc.

Receive notifications about Physiomics Plc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.